Traditional Chinese medicine composition for treating chronic hepatitis B and preparation method thereof
A technology of chronic hepatitis B and its composition, which is applied in the field of traditional Chinese medicine composition and its preparation for the treatment of chronic hepatitis B, which can solve the problems of large toxic and side effects, harm to patients, and inaccurate curative effect, and achieve significant therapeutic effect and improve immune function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0032] (1) A kind of Chinese medicine for the treatment of chronic hepatitis B, which is formed by the proportioning of the following raw materials by weight:
[0033] 30 parts of Nepeta chinensis, 25 parts of yellow root, 20 parts of gentian safflower, 15 parts of goldenseal, 15 parts of Akane Ibe, 10 parts of chicory, 10 parts of sweet tea vine, 10 parts of popcorn, 10 parts of lilac, 5 parts of Radix Isatidis and 5 parts of Astragalus.
[0034] (2) Preparation method:
[0035] In the first step, the yellow root and gentian safflower are mixed in proportion, extracted twice with n-propanol having an alcohol concentration of 70% equivalent to twice the mass of the mixture, and the filtrates are combined, concentrated under reduced pressure, dried and pulverized into powder, Then purify with ethanol for 1-2 times, combine the extracts, recover the ethanol under reduced pressure and concentrate to a paste with a relative density of 1.21-1.24 at 60°C, dry and pulverize into pow...
Embodiment 2
[0040] (1) a kind of Chinese medicine for the treatment of chronic hepatitis B is formed by the proportioning of following crude drugs by weight: with embodiment 1.
[0041] (2) Preparation method:
[0042]In the first step, the yellow root and gentian safflower are mixed in proportion, extracted twice with n-propanol having an alcohol concentration of 70% equivalent to twice the mass of the mixture, and the filtrates are combined, concentrated under reduced pressure, dried and pulverized into powder, Then purify once with ethanol, combine the extracts, recover ethanol under reduced pressure and concentrate to a paste with a relative density of 1.21-1.24 at 60°C, dry and pulverize into powder;
[0043] The second step is to extract 2 times with the n-propanol with 80% alcohol concentration of Kingsberry, Chrysanthemum japonica, Chicory, and sweet tea vine, combine the extracts, concentrate under reduced pressure, dry, and pulverize into powder, and the pulverized The powder w...
Embodiment 3
[0047] 1. Long-term toxicity test process:
[0048] Apply Wistar rats (Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. provides) experimental medicine is set to high, medium and low three dosages, be respectively the capsule 8g / kg, 4g / kg, 2g of embodiment 1 formula / kg. Calculated according to the human dose of 0.1g / kg / day tablet, it is 80 times, 40 times and 20 times of the effective dose for human respectively; another control group is set up, which is given continuously for 90 days and 180 days by intragastric administration and part of the animals are withdrawn for 10 days. Days later, the effects on various physiological and biochemical indicators of rats were observed. The experimental results show that: continuous oral administration of different doses to rats for 180 days has no effect on the food intake and weight growth of the rats. No significant toxic effects were found on liver and kidney function. There was no obvious effect on blood routine, bl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com